Thrombotic Microangiopathy in Inverted Formin 2–Mediated Renal Disease

The demonstration of impaired C regulation in the thrombotic microangiopathy (TMA) atypical hemolytic uremic syndrome (aHUS) resulted in the successful introduction of the C inhibitor eculizumab into clinical practice. C abnormalities account for approximately 50% of aHUS cases; however, mutations i...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:J Am Soc Nephrol
Egile Nagusiak: Challis, Rachel C., Ring, Troels, Xu, Yaobo, Wong, Edwin K.S., Flossmann, Oliver, Roberts, Ian S.D., Ahmed, Saeed, Wetherall, Michael, Salkus, Giedrius, Brocklebank, Vicky, Fester, Julian, Strain, Lisa, Wilson, Valerie, Wood, Katrina M., Marchbank, Kevin J., Santibanez-Koref, Mauro, Goodship, Timothy H.J., Kavanagh, David
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: American Society of Nephrology 2017
Gaiak:
Brief Communications
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC5373440/
https://ncbi.nlm.nih.gov/pubmed/27974406
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1681/ASN.2015101189
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak